SeaStar Medical Holding Corporation - Common Stock Share · US81256L1044 · ICU (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview

AI-Powered Analysis

Fundamental Analysis

Find out what the numbers really say — before the market does

Analyze now

News Sentiment

Are today's headlines a buy signal or a red flag?

Analyze now

Buy / Hold / Sell

Should you Buy, Hold, or Sell? Get the AI verdict now.

Analyze now

Risk Assessment

Uncover hidden risks before they hit your portfolio.

Analyze now

Fair Value

Is this stock cheap, fairly priced, or overvalued?

Analyze now

Latest AI Analyses of SeaStar Medical Holding Corporation - Common Stock

Analyst Grade Summary

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

No Price

01.05.2026 23:52

Current Prices from SeaStar Medical Holding Corporation - Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	ICU	USD	01.05.2026 23:52	4,35 USD	0,21 USD +5,07 %
IEX	ICU	USD	01.05.2026 19:57	4,43 USD	0,29 USD +7,00 %

Share Float & Liquidity

Free Float 99,32 %

Shares Float 2,77 M

Shares Outstanding 2,79 M

Company Profile for SeaStar Medical Holding Corporation - Common Stock Share

SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. It is developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure with and without LVAD; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is based in Denver, Colorado.